The Apex Times
Above the Noise
Business Wire
BusinessPfizer and BioNTech say FDA approved a supplemental COVID-19 vaccine adapted for XFG variantThe Apex TimesBusinessDelta marks a decade of Seahawks rewards with relaunch of 12Status in WashingtonThe Apex TimesBusinessJensen Huang tells investors open and closed AI models can both lift Nvidia’s chip demandThe Apex TimesBusinessCoinbase CEO Brian Armstrong says bitcoin could hit $400,000 by 2030, pointing to long-term crypto adoptionThe Apex TimesBusinessOracle shares jumped about 18% in a month, sharpening the debate over whether the move is a durable comebackThe Apex TimesBusinessSalesforce shares jump after Q2 results, as investors refocus on AI-driven growthThe Apex TimesBusinessCRISPR Therapeutics shares ease about 3% even after “encouraging” CTX310 trial updates, Morgan Stanley flags next readoutsThe Apex TimesBusinessJim Cramer urges investors to “own” NVIDIA after another blowout quarterThe Apex TimesBusinessMeta’s closed-loop cooling approach points to a more scalable path for AI data centersThe Apex TimesBusinessMicrosoft shares rise about 14% in a month, reviving the question of when to take profitsThe Apex TimesBusinessChevron and Halliburton Shares Rise as Both Eye New Activity Tied to Venezuela’s Oil SectorThe Apex TimesBusinessBroadcom edges AMD on AI-chip risk-reward in Yahoo Finance analysis, citing diversification and valuationThe Apex TimesBusinessPfizer and BioNTech say FDA approved a supplemental COVID-19 vaccine adapted for XFG variantThe Apex TimesBusinessDelta marks a decade of Seahawks rewards with relaunch of 12Status in WashingtonThe Apex TimesBusinessJensen Huang tells investors open and closed AI models can both lift Nvidia’s chip demandThe Apex TimesBusinessCoinbase CEO Brian Armstrong says bitcoin could hit $400,000 by 2030, pointing to long-term crypto adoptionThe Apex TimesBusinessOracle shares jumped about 18% in a month, sharpening the debate over whether the move is a durable comebackThe Apex TimesBusinessSalesforce shares jump after Q2 results, as investors refocus on AI-driven growthThe Apex TimesBusinessCRISPR Therapeutics shares ease about 3% even after “encouraging” CTX310 trial updates, Morgan Stanley flags next readoutsThe Apex TimesBusinessJim Cramer urges investors to “own” NVIDIA after another blowout quarterThe Apex TimesBusinessMeta’s closed-loop cooling approach points to a more scalable path for AI data centersThe Apex TimesBusinessMicrosoft shares rise about 14% in a month, reviving the question of when to take profitsThe Apex TimesBusinessChevron and Halliburton Shares Rise as Both Eye New Activity Tied to Venezuela’s Oil SectorThe Apex TimesBusinessBroadcom edges AMD on AI-chip risk-reward in Yahoo Finance analysis, citing diversification and valuationThe Apex TimesBusinessPfizer and BioNTech say FDA approved a supplemental COVID-19 vaccine adapted for XFG variantThe Apex TimesBusinessDelta marks a decade of Seahawks rewards with relaunch of 12Status in WashingtonThe Apex TimesBusinessJensen Huang tells investors open and closed AI models can both lift Nvidia’s chip demandThe Apex TimesBusinessCoinbase CEO Brian Armstrong says bitcoin could hit $400,000 by 2030, pointing to long-term crypto adoptionThe Apex TimesBusinessOracle shares jumped about 18% in a month, sharpening the debate over whether the move is a durable comebackThe Apex TimesBusinessSalesforce shares jump after Q2 results, as investors refocus on AI-driven growthThe Apex TimesBusinessCRISPR Therapeutics shares ease about 3% even after “encouraging” CTX310 trial updates, Morgan Stanley flags next readoutsThe Apex TimesBusinessJim Cramer urges investors to “own” NVIDIA after another blowout quarterThe Apex TimesBusinessMeta’s closed-loop cooling approach points to a more scalable path for AI data centersThe Apex TimesBusinessMicrosoft shares rise about 14% in a month, reviving the question of when to take profitsThe Apex TimesBusinessChevron and Halliburton Shares Rise as Both Eye New Activity Tied to Venezuela’s Oil SectorThe Apex TimesBusinessBroadcom edges AMD on AI-chip risk-reward in Yahoo Finance analysis, citing diversification and valuationThe Apex TimesBusinessPfizer and BioNTech say FDA approved a supplemental COVID-19 vaccine adapted for XFG variantThe Apex TimesBusinessDelta marks a decade of Seahawks rewards with relaunch of 12Status in WashingtonThe Apex TimesBusinessJensen Huang tells investors open and closed AI models can both lift Nvidia’s chip demandThe Apex TimesBusinessCoinbase CEO Brian Armstrong says bitcoin could hit $400,000 by 2030, pointing to long-term crypto adoptionThe Apex TimesBusinessOracle shares jumped about 18% in a month, sharpening the debate over whether the move is a durable comebackThe Apex TimesBusinessSalesforce shares jump after Q2 results, as investors refocus on AI-driven growthThe Apex TimesBusinessCRISPR Therapeutics shares ease about 3% even after “encouraging” CTX310 trial updates, Morgan Stanley flags next readoutsThe Apex TimesBusinessJim Cramer urges investors to “own” NVIDIA after another blowout quarterThe Apex TimesBusinessMeta’s closed-loop cooling approach points to a more scalable path for AI data centersThe Apex TimesBusinessMicrosoft shares rise about 14% in a month, reviving the question of when to take profitsThe Apex TimesBusinessChevron and Halliburton Shares Rise as Both Eye New Activity Tied to Venezuela’s Oil SectorThe Apex TimesBusinessBroadcom edges AMD on AI-chip risk-reward in Yahoo Finance analysis, citing diversification and valuationThe Apex Times
Back to front
AM Best affirms UnitedHealth’s credit ratings at “a-,” maintaining long- and short-term issue ratings
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 28, 2:49 PM EDT

AM Best affirms UnitedHealth’s credit ratings at “a-,” maintaining long- and short-term issue ratings

The rating agency said it reaffirmed UnitedHealth Group’s long-term issuer credit rating and related long- and short-term issue credit ratings for the company and its subsidiaries.

2 min readEditor-approved Apex article

UnitedHealth Group’s credit profile received an affirmation from AM Best on August 28, with the agency maintaining the company’s long-term issuer credit rating at “a-” (Excellent).

In the same announcement, AM Best also affirmed UnitedHealth’s long- and short-term issue credit ratings, including the long-term and short-term issue ratings for UnitedHealth and its subsidiaries, keeping the ratings unchanged as of the review date.

The action is notable because AM Best ratings are closely watched in financial markets and by business partners for what they suggest about an insurer’s long-term ability to meet obligations. For UnitedHealth, the affirmation indicates that AM Best did not identify new factors that would require a downgrade at the time of the review.

The announcement, as published by Yahoo Finance, did not provide additional granular drivers such as changes in leverage, reserve adequacy, operating performance, or capital metrics. It also did not outline any specific conditions or outlook language in the excerpt available for review.

UnitedHealth Group, a major player in U.S. health coverage and services, operates in a segment where credit quality can matter for counterparties and for the broader ecosystem of providers, managed-care arrangements, and financing needs. Rating stability can be particularly relevant for companies with large insurance and services footprints, since they manage substantial ongoing obligations across many lines of business.

Even without further detail in the published item, the reaffirmation suggests AM Best considered UnitedHealth’s overall creditworthiness and insurance risk profile to be consistent with the current rating band. The maintenance of both issuer and issue ratings indicates the agency treated the company and its subsidiaries as warranting continued alignment across those rating measures.

What remains unclear from the published notice is whether AM Best tied the affirmation to a routine review process, whether any rating actions occurred elsewhere in the group, and whether there were any quantified financial benchmarks cited. The company also did not disclose any additional context in the Yahoo Finance posting beyond the headline affirmation of the ratings.

Investors and analysts typically watch for any subsequent rating agency follow-ups, changes in rating outlooks, or indicates from company disclosures that could affect insurer credit factors. The next test for readers will be whether future AM Best communications expand on the rationale and whether any separate rating actions emerge for specific subsidiaries or issues.

Why It Matters

  • Credit ratings can influence market perceptions of insurer strength and may affect how counterparties evaluate risk.
  • Maintaining both issuer and issue ratings suggests AM Best saw no immediate need to revise UnitedHealth’s credit standing as of the review date.
  • Rating stability may reduce uncertainty for financing and long-term obligations relative to a downgrade scenario.
  • The lack of disclosed rationale in the published item means observers will likely look to later AM Best commentary or company filings for drivers.

Sources

Key Facts

  • AM Best affirmed UnitedHealth Group Incorporated’s long-term issuer credit rating at “a-” (Excellent).
  • AM Best also affirmed UnitedHealth’s long-term and short-term issue credit ratings for UnitedHealth and its subsidiaries.
  • The ratings affirmation was published on August 28, 2026.
  • The announcement, as presented in the Yahoo Finance item, did not include additional operational or financial justification beyond the ratings maintenance.

Healthcare Related

Aug 28, 1:17 PM EDT
The Apex Times

David Tepper exits UnitedHealth as focus returns to fair value accounting

The hedge-fund manager’s sale of his UnitedHealth Group position is prompting investors to re-check how the company measures and reports fair value assets and liabilities, even as the broader healthcare giant continues to operate on steady core fundamentals.

David Tepper exits UnitedHealth as focus returns to fair value accounting
The Apex Times